Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant

Abstract Lemborexant, a dual orexin receptor antagonist, is approved in the United States, Japan, and Canada for the treatment of insomnia in adults. This phase I, multicenter, open‐label, parallel‐group study assessed the impact of mild or moderate hepatic impairment (HI) on lemborexant pharmacokin...

Full description

Saved in:
Bibliographic Details
Main Authors: Satish Dayal (Author), Jagadeesh Aluri (Author), Nancy Hall (Author), Gleb Filippov (Author), Margaret Moline (Author), Larisa Reyderman (Author), Ishani Landry (Author)
Format: Book
Published: Wiley, 2021-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available